Grifols (GRFS) EBT (2010 - 2020)
Grifols' (GRFS) quarterly EBT came in at $277.4 million in Q1 2020, up 70.84% YoY from $162.4 million in Q2 2019, and down 55.09% on a QoQ basis from $617.6 million in Q4 2019.
Grifols (GRFS) EBT (2010 - 2020) Analysis & Trends
Grifols (GRFS) has 11 years of EBT data on file, last reported at $277.4 million in Q1 2020.
- Quarterly EBT rose 70.84% year-over-year to $277.4 million in Q1 2020, while the trailing twelve-month figure through Mar 2020 was $1.7 billion (up 26.65% YoY) and the FY2025 annual result came in at $715.9 million, up 50.89% from the prior year.
- EBT slipped to $277.4 million in Q1 2020, from $617.6 million in the prior quarter.
- In the past five years, EBT ranged from a high of $694.7 million in Q4 2017 to a low of $22.3 million in Q4 2016.
- A 5-year average of $337.0 million and a median of $277.4 million in 2020 frame the typical range for EBT.
- The widest YoY moves for EBT: up 3021.96% in 2017, down 48.82% in 2017.
- Tracing GRFS's EBT over 5 years: stood at $22.3 million in 2016, then soared by 3021.96% to $694.7 million in 2017, then decreased by 3.93% to $667.4 million in 2018, then declined by 7.46% to $617.6 million in 2019, then plunged by 55.09% to $277.4 million in 2020.
- The last three EBT figures came in at $277.4 million (Q1 2020), $617.6 million (Q4 2019), and $162.4 million (Q1 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.40 Bn | 624.64 Bn | 17.26 Bn | 6.75 Bn |
| 2 | AbbVie | 462.79 Bn | 456.22 Bn | 12.70 Bn | 4.28 Bn |
| 3 | Merck | 369.55 Bn | 362.41 Bn | 12.21 Bn | -683.00 Mn |
| 4 | Novartis Ag | 298.79 Bn | 291.10 Bn | 11.24 Bn | 4.27 Bn |
| 5 | Astrazeneca | 255.57 Bn | 250.67 Bn | 12.86 Bn | 2.80 Bn |
| 6 | Amgen | 233.87 Bn | 219.89 Bn | 7.24 Bn | 2.77 Bn |
| 7 | Gilead Sciences | 179.24 Bn | 176.06 Bn | 6.22 Bn | -10.25 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | -653.00 Mn |
| 9 | Gsk | 104.53 Bn | 100.36 Bn | 8.24 Bn | 474.95 Mn |
| 10 | Grifols | 5.49 Bn | 4.49 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 277.39 Mn |
| Dec 31, 2019 | 617.65 Mn |
| Mar 31, 2019 | 162.37 Mn |
| Dec 31, 2018 | 667.42 Mn |
| Jun 30, 2018 | 312.31 Mn |
| Mar 31, 2018 | 219.83 Mn |
| Dec 31, 2017 | 694.73 Mn |
| Jun 30, 2017 | 313.51 Mn |
| Mar 31, 2017 | 195.18 Mn |
| Dec 31, 2016 | 22.25 Mn |
| Sep 30, 2016 | 267.29 Mn |
| Jun 30, 2016 | 249.95 Mn |
| Mar 31, 2016 | 381.34 Mn |
| Dec 31, 2015 | -30.43 Mn |
| Sep 30, 2015 | 275.09 Mn |
| Jun 30, 2015 | 258.96 Mn |
| Mar 31, 2015 | 267.05 Mn |
| Dec 31, 2014 | -531.60 Mn |
| Sep 30, 2014 | 180.98 Mn |
| Jun 30, 2014 | 184,109.30 |